The short answer

Some specific probiotic strains can reduce antibiotic-associated diarrhoea, but “a probiotic” is not one interchangeable treatment. Benefit depends on strain, dose, population, antibiotic setting and when it is started. An outpatient meta-analysis[1] found diarrhoea in 8.0% of probiotic users versus 17.7% of controls, but trials varied and the result cannot be applied to every product on a New Zealand shelf.

In this article
Probiotics and antibiotic-associated diarrhoea: Supplement Solutions editorial illustration
Gut health guide · Supplement Solutions

Ask the antibiotic prescriber or pharmacist whether a probiotic is suitable, especially for a child, pregnancy, serious illness, immune suppression, a central venous line, or persistent/severe diarrhoea.

Separate prevention from treatment

QuestionEvidence boundary
Can a probiotic reduce the chance of antibiotic-associated diarrhoea?Some named strains/products have supportive trials
Will any multi-strain product work?No; more strains is not proof
Can it treat severe diarrhoea or C. difficile infection?No retail self-treatment; seek medical care
Does it restore the microbiome to its original state?Microbiome measures vary and a clinical “reset” is not established
Should it begin only after the antibiotic course?Many prevention trials started near antibiotic initiation; follow clinician/product evidence

The absolute outpatient result means about 10 fewer people with diarrhoea per 100 treated in those pooled trials. Baseline risk changes with antibiotic, age and setting, so an individual benefit may be smaller or larger.

Strain names are the evidence address

Probiotic effects can be strain-specific. Lacticaseibacillus rhamnosus GG is not interchangeable with every L. rhamnosus; Saccharomyces boulardii CNCM I-745 is not every yeast product. A 2018 systematic review found different effects even within the same species.

A useful label provides:

  • genus, species and strain designation;
  • colony-forming units (CFU) at the end of shelf life, not only manufacture;
  • daily serving used in relevant studies;
  • storage requirements and expiry;
  • allergen/excipient information;
  • evidence for the same population and outcome.

If the label says only “10 billion probiotics” or lists a proprietary blend without strain-level amounts, the research match cannot be checked.

Timing depends on the organism and antibiotic

Many trials started the probiotic at the same time as, or within a short period of, antibiotics and continued for a defined time. Bacterial probiotics are often separated from the antibiotic dose, while S. boulardii is a yeast and is not killed by antibacterial medicines. This does not create a universal timing rule: antibiotics, formulations and clinical directions differ.

Do not delay or alter the antibiotic to accommodate a supplement. Ask the pharmacist to write the timing on the medicine label or plan.

Food and “probiotic foods” are a different decision

Yoghurt, kefir, kimchi and other fermented foods may fit a nutritious diet but do not necessarily contain the studied strain or dose. Fermentation does not guarantee live organisms at consumption, and pasteurisation/storage matters.

Food can still help restore a normal eating pattern after illness: adequate fluids, energy, protein and fibre as tolerated. For general food-planning support, see Inception Nutrition. If you need clinical nutrition advice, use a registered dietitian and verify the provider's qualifications and scope. Severe symptoms need medical care.

When diarrhoea needs assessment

Contact a clinician promptly for:

  • blood in stool, severe abdominal pain or marked distension;
  • fever, repeated vomiting or inability to maintain fluids;
  • low urine output, severe dizziness or confusion;
  • frequent/watery diarrhoea during or after antibiotics;
  • symptoms in an older/frail person, young child or immunocompromised person;
  • diarrhoea that persists or worsens.

Clostridioides difficile can occur during or after antibiotics and needs testing/treatment. A probiotic should not postpone that pathway, and evidence about prevention does not establish that a probiotic cures infection.

Who should not self-start

Cases of bloodstream or invasive infection from probiotic organisms are rare but have occurred, mainly in severely ill or immunocompromised people and those with central lines or disrupted gut barriers. Premature infants and intensive-care patients require specialist protocols.

Pregnancy and childhood also need product-specific advice because studies and formulations differ. A gummy marketed to families is not proof of paediatric evidence.

Compare cost against a verifiable match

Calculate cost for the full evidence-matched course, not per capsule. A lower-cost product with no strain designation may be impossible to link to trials. A higher price also does not prove viability.

Before purchase, ask the seller for a full current label and batch/expiry information. For products requiring refrigeration, consider transport temperature and what happens after opening.

Frequently asked questions

What is the best probiotic after antibiotics?

There is no universal winner. Match exact strain/product evidence to the population and antibiotic context with a pharmacist or clinician.

Should I take it during or after antibiotics?

Prevention trials often start during the antibiotic course. Follow the evidence and instructions for the exact organism; do not guess from a generic article schedule.

Are multi-strain probiotics better?

Not automatically. Some meta-analyses find subgroup differences, but the exact combination and dose matter. Ingredient count is not comparative evidence.

Can probiotics cause bloating?

Gas and digestive symptoms can occur, and added inulin/sugar alcohols may be the cause. Stop and seek advice if symptoms are severe or systemic.

Do I need a probiotic every time I take antibiotics?

No blanket rule applies. Baseline diarrhoea risk, previous history, health status, antibiotic and preference determine potential value.

References

  1. 1.
    Blaabjerg et al., outpatient systematic review: absolute diarrhoea rates, pooled relative effect and heterogeneity.
  2. 2.
    McFarland et al., strain-specific systematic review: strain/disease specificity and limits of pooling probiotics.
  3. 3.
    Wanyama et al., 2025 meta-analysis: more recent adult trials and heterogeneity; not product-class proof.
  4. 4.
    AGA guideline on probiotics: clinical recommendations and strain-specific combinations; US context.
  5. 5.
    Health New Zealand: Dietary supplements: current NZ supplement overview mentioning selected antibiotic contexts.
  6. 6.
    Health New Zealand: C. difficile infection: local symptoms and clinical pathway.
  7. 7.
    ASA Therapeutic and Health Advertising Code: disease/therapeutic advertising boundaries.

This guide provides general education, not diagnosis or individual medical advice. Follow product labels and speak with an appropriately qualified health professional when you are pregnant, nursing, taking medication or managing a health condition.

Back to supplement guides